• Catalpol and Cardio-Cerebrovascular Protection

  2026-09-01

  This comprehensive review synthesizes preclinical evidence that catalpol may protect the cardiovascular and cerebrovascular systems through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and mitochondrial mechanisms. Its main practical contribution is a pathway- and disease-oriented framework that clarifies therapeutic promise while emphasizing the limited clinical evidence and need for better pharmacokinetic and translational studies.

• Octenidine Dihydrochloride in Assay Design

  2026-08-31

  Octenidine dihydrochloride is a cationic antiseptic small molecule whose membrane activity makes it valuable for controlled antimicrobial research. This guide focuses on assay architecture, formulation, controls, and how recent gemini-quaternary-ammonium research should influence experimental decisions.

• p-tau Ser356, NUAK Inhibition, and AD Pathology

  2026-08-31

  This Acta Neuropathologica study establishes that tau phosphorylated at Ser356 tracks with Alzheimer’s disease progression, appears broadly in neurofibrillary tangles, and is associated with synaptic structures. Using mouse organotypic and live human brain slice cultures, the authors further show that NUAK inhibition produces model-dependent effects, including selective reduction of p-tau Ser356 in human tissue.

• Arrb2, 6-ketoLCA, and Hepatic IRI

  2026-08-30

  This study identifies hepatocyte Arrb2 as a regulator of hepatic ischemia–reperfusion injury, linking parenchymal signaling to 6-ketoLCA production and M2 macrophage polarization. Its combination of clinical samples, hepatocyte-focused mouse genetics, metabolomics, and hypoxia–reoxygenation models provides a useful framework for dissecting hepatocyte–macrophage crosstalk.

• Amitriptyline HCl: A Smarter BBB Research Strategy

  2026-08-29

  A translational framework for using Amitriptyline HCl to connect receptor pharmacology, blood-brain barrier transport, intracellular sequestration, and CNS model interpretation.

• Cell Counting Kit-8 Plus for Viability Studies

  2026-08-28

  Cell Counting Kit-8 Plus converts viable-cell dehydrogenase activity into a rapid, water-soluble WST-8 signal for proliferation, cytotoxicity, and drug-response workflows. Its short 0.5–1 hour development window is especially useful for mechanistic studies of macrophage injury without requiring cell lysis.

• Phenothiazines Boost Macrophage Antibacterial Activity

  2026-08-28

  Qiu and colleagues identify a host-directed mechanism by which phenothiazines strengthen macrophage control of intracellular bacteria: coordinated increases in lysosomal activity, autophagy, and reactive oxygen species. Pharmacologic blockade of autophagy or ROS substantially weakened this effect, while perphenazine reduced pathology in a Salmonella Typhimurium infection model, supporting phenothiazines as lead compounds rather than established antibacterial therapies.

• Panoramic Hyperspectral Cardiac Mapping

  2026-08-27

  Kowalik and colleagues introduce a multimodal system that co-registers epicardial tissue type with transmembrane-potential maps across the surface of infarcted rat hearts. By linking collagen-sensitive hyperspectral signals to action-potential behavior, the study identifies infarct-border regions associated with premature ventricular contractions and reentrant activity, offering a stronger structure–function framework for arrhythmia research.

• Tamsulosin for Ureteral Stone Passage: Meta-Analysis

  2026-08-27

  This systematic review and meta-analysis addressed conflicting evidence on whether Tamsulosin improves spontaneous passage of symptomatic ureteral stones. By pooling data across diverse clinical studies, it found higher expulsion rates and shorter passage times without a clear increase in overall adverse effects, while also highlighting the importance of stone size and study context.

• Ertugliflozin: From SGLT2 Biology to Study Design

  2026-08-26

  Ertugliflozin (PF-04971729) offers a precise model of renal glucose reabsorption inhibition. This article connects SGLT2 mechanism, weight-loss evidence, translational endpoints, and practical assay design while distinguishing clinical dosing from experimental exposure.

• Levofloxacin: Mechanism-to-Assay Translation

  2026-08-26

  Levofloxacin connects bacterial DNA replication pathway studies with bone-cell research. This guide distinguishes direct product evidence from transferable PK/PD principles and develops a rigorous framework for interpreting osteoblast, mineralization, and chondrocyte assays.

• Annexin V-Cy5 Apoptosis Kit in Microglia

  2026-08-25

  The Annexin V-Cy5 Apoptosis Kit helps distinguish genuine phosphatidylserine exposure from lysosomal stress in microglia. This guide translates a reversible mestranol model into a rigorous strategy for flow cytometry apoptosis detection, fluorescence imaging, and temporal assay design.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-08-25

  Build faster, cleaner interaction assays with magnetic Protein A/G capture, from BMSC lysates to SDS-PAGE and mass spectrometry. This guide translates a recent PML–HIF1AN study into practical co-IP design, controls, optimization steps, and troubleshooting for complex protein samples.

• Betaine hydrochloride in Inflammation Assays

  2026-08-24

  Use Betaine hydrochloride as a controlled, water-soluble screening variable in metabolic enzyme research, protease assays, and carefully qualified cancer-inflammation workflows. This guide connects practical solution preparation and matrix controls with the TLR4/NF-κB/NLRP3 findings reported in an esophageal cancer model—without confusing assay support with demonstrated antitumor efficacy.

• MK 0893: Practical Glucagon Receptor Antagonist Workflows

  2026-08-24

  MK 0893 combines nanomolar GCGR potency with a structurally defined allosteric mechanism, making it useful for both receptor-binding studies and functional cAMP assays. This guide translates the compound’s binding-site biology into reproducible cell workflows, in vivo study design, and practical troubleshooting for type 2 diabetes research.

8112 records 2/541 page Previous Next 12345 下5页 Last page